Fulgent Diagnostics is a leader in clinical genetic and genomic testing. We are a publicly traded company headquartered in Los Angeles, California, with labs in China and Canada. We are a technology-driven company with extensive academic/clinical experience and state-of-the-art capabilities in Next Generation Sequencing and bioinformatics. Fulgent's proprietary engineered genetic probes, enhanced variant filtering and prioritization algorithms and software tools specifically designed to enhance curation process, propelled our rapid growth to the forefront of the clinical genetic and genomic testing industry in the recent years. We are a CLIA and CAP accredited laboratory and offer the most expansive set of clinical genetic tests in the world, including 18,000+ single gene tests, 390+ preset panels, clinical exome, whole exome and whole genome sequencing. All our testing options are highly customizable allowing clinicians to provide personalized genetic testing specific to the individual needs of the patients.
